Additionally, in obese patients, leptin may contribute to obesity-related glomerulopathy, potentially stimulating the renin–angiotensin–aldosterone system and exacerbating proteinuria and CKD [53]. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.